PRESENTED BY
Levana Sani

NOMINATED BY
A*Star

 

Nalagenetics Pte Ltd is a medtech company focused on the personalization of dosing and prescription. Our mission is to provide actionable and cost-effective pharmacogenomics (PGx) testing for developing countries, starting with Southeast Asia. Trial-error is the status quo of prescription methods although 48% of them cause the prescription error and 64.7% of adverse drug reactions (ADR) caused are preventable. ADR cause 8-12% of hospital admissions and is the 4th leading cause of death in the US. Although 30-70% of ADR have genetic associations, genetic testing for drug response (PGx testing) in developing countries is not widely adopted because it is too expensive and unproven in local populations. Thus, we develop an affordable and actionable PGx testing backed with clinical decision support to aggregate real-world-evidence data for a better prescription.

Our technology called the NalaTM PGx Suite is an end-to-end PGx testing service, comprises of a clinical-grade genetic test and software solutions. The PGx testing is a 3-5x cheaper clinical-grade genomic assay that consists of curated biomarkers to predict the risk of drug responses. The biomarkers tested on our panel have been selected by our proprietary algorithm considering the most updated guidelines, scientific evidence, and local relevance. Our clinical decision support system helps physicians to choose alternative therapies and calculate dosing based on the patients’ genetic profile. Our patient engagement platform ensures the patient’s personalized prescription delivers impact by facilitating interaction beyond the point of prescription with our Patient Care Manager and Genetic Counselor.

More Venture Finalists

All Venture Finalists

Further Activities to have a look at

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.